Roseburia hominis

Roseburia hominis is a bacterium first isolated from human feces. It is anaerobic, Gram-negative or Gram-variable, slightly curved rod-shaped and motile. The cells range in size from 0.5-1.5 to 5.0 μm. A2-183(T) (=DSM 16839(T)=NCIMB 14029(T)) is the type strain.[1]

Roseburia hominis
Scientific classification
Domain: Bacteria
Phylum: Bacillota
Class: Clostridia
Order: Eubacteriales
Family: Lachnospiraceae
Genus: Roseburia
Species:
R. hominis
Binomial name
Roseburia hominis
Duncan et al. 2006

It is being studied as a potential treatment for ulcerative colitis in pediatric patients ages 0 through 16 years.[2]

References

  1. Sylvia H. Duncan; Rustam I. Aminov; Karen P. Scott; Petra Louis; Thaddeus B. Stanton & Harry J. Flint (October 2006). "Proposal of Roseburia faecis sp. nov., Roseburia hominis sp. nov. and Roseburia inulinivorans sp. nov., based on isolates from human faeces". International Journal of Systematic and Evolutionary Microbiology. 56 (Pt 10): 2437–2441. doi:10.1099/ijs.0.64098-0. PMID 17012576.
  2. "Orphan Drug Designations and Approvals". Food and Drug Administration.

Further reading


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.